首页> 外国专利> ANTI-HUMAN UROTHELIAL CARCINOMA OF SUPERCRITICAL CARBON DIOXIDE EXTRACT OF CINNAMOMUM SUBAVENIUM, AND THE PREPARATION PROCESS AND USES

ANTI-HUMAN UROTHELIAL CARCINOMA OF SUPERCRITICAL CARBON DIOXIDE EXTRACT OF CINNAMOMUM SUBAVENIUM, AND THE PREPARATION PROCESS AND USES

机译:肉桂腈超临界二氧化碳萃取物的抗人尿道上皮癌及其制备方法和用途

摘要

What is disclosed in the invention is a preparation method of a supercritical Cinnamomum subavenium extract, which is made from the material, the dried stem of C. subavenium. The extract is obtained by extracting C. subavenium which is pulverized as particles with supercritical carbon dioxide fluid. The C. subavenium extract or its active ingredient, subamolide A, can be used to inhibit the growth of human urothelial carcinoma cell lines. In addition, the C. subavenium extract (or subamolide A) is able to synergistically inhibit the growth of human urothelial carcinoma cell lines with cisplatin (CDDP) or gemcitabine (Gem). Therefore, the C. subavenium extract (or subamolide A) can be an anticancer drug alone, or forms a pharmaceutical composition with CDDP (or Gem) to treat with cancers in respect of urinary system.
机译:本发明公开了一种超临界肉桂肉桂提取物的制备方法,该超提取物由干燥的茎秆材料制成。亚馆。 提取物是通过提取 C获得的。用超临界二氧化碳流体将其粉碎成微粒子。 C。 subavenium 提取物或其有效成分Subamolide A可用于抑制人尿路上皮癌细胞株的生长。另外, C。 Subavenium 提取物(或Subamolide A)能够与顺铂(CDDP)或吉西他滨(Gem)协同抑制人尿路上皮癌细胞系的生长。因此, C。 Subavenium 提取物(或Subamolide A)可以单独使用抗癌药,也可以与CDDP(或Gem)形成药物组合物以治疗泌尿系统癌症。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号